Cystic Fibrosis Therapeutics size, Trends and Industry Analysis

Cystic Fibrosis Therapeutics Market Cystic Fibrosis Therapeutics Market Comprehensive Study with Key Trends, Major Drivers and Challenges Sample View Report

Cystic Fibrosis Therapeutics Market Outlook, Growth Factors, Industry Share, Size By 2030 Cystic Fibrosis (CF) is a genetic disease that affects mainly the respiratory, digestive, and reproductive systems. The disease is caused by a mutation in the CFTR gene, which encodes for a protein that regulates the transport of chloride ions across cell membranes. There is no cure for CF, but there are several therapeutics available to manage the symptoms and slow the progression of the disease. Some of the most commonly used CF therapeutics are: According to Straits Research The global cystic fibrosis therapeutics market size was valued at USD 6.33 billion in 2021 and is expected to reach USD 13.88 billion in 2030 expanding at a CAGR of 9.12%. The CF therapeutics market is segmented by drug class, including CFTR modulators, mucolytics, antibiotics, pancreatic enzyme replacement therapy, bronchodilators, and others. CFTR modulators are the largest segment, accounting for over half of the market share. Within the CFTR modulator class, the combination drug Lumacaftor/Ivacaftor has been the largest contributor to the market revenue. Geographically, the North American region dominates the cystic fibrosis therapeutics market, followed by Europe. The increasing prevalence of cystic fibrosis, the high adoption rate of novel therapies, and favorable reimbursement policies are some of the key factors driving the growth of the market in these regions.

Cystic Fibrosis Therapeutics Market CAGR 9.12 % (2022-2030) 13.88 Billion 6.33 Billion Request Sample 2021 2030

Cystic Fibrosis Therapeutics Market Main Market Players Covered A Summary of the Impact of COVID-19 in This Report: on this Market: ✓ Vertex Pharmaceutical Incorporated The appearance of COVID-19 has transported the globe to ✓ Roche a halt. We understand that this health disaster has brought ✓ Nestle Health Science an unprecedented impact on businesses across industries. ✓ AbbVie However, this too shall pass. Growing support from ✓ Viatris Inc. governments and various companies can benefit in the ✓ Horizon Therapeutic Plc. fight against this highly transmissible disease. There are ✓ Gilead Sciences some businesses that are struggling and some are thriving. ✓ Chiesi Farmacrutici General, almost every sector is anticipated to be stuck by ✓ Pharmaxis Ltd. the pandemic

Cystic Fibrosis Therapeutics Market The Cystic Fibrosis Therapeutics Market has been segmented as below: ✓ By Drug Class:Pancreatic Enzyme Supplements, Mucolytics, Bronchodilators, CFTR ModulatorsBy ✓ By Route of Administration: Oral Drugs, Inhaled Drugs ✓ By Regions:- North America, Europe, Asia-Pacific, LAMEA We are taking nonstop efforts to help your business sustain and cultivate during COVID-19 pandemics. Based on our knowledge and expertise, we will provide you an impact analysis of coronavirus outbreaks across businesses to help you prepare for the future. Thanks for reading this article; you can also get distinct chapter-wise sections or region-wise report versions like Asia, US, Europe, Africa, etc.

About Straits Research StraitsResearch.com is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. www.straitsresearch.com 825 3rd Avenue, New York, NY, USA, UK: +44 203 695 0070, USA: +1 646 905 0080 [email protected]